抗抑郁药
药品
药物发现
萧条(经济学)
机制(生物学)
医学
药物开发
药理学
精神科
生物信息学
生物
焦虑
哲学
宏观经济学
认识论
经济
作者
Chuansheng Yao,Xiaoying Jiang,Xiang‐Yang Ye,Tian Xie,Renren Bai
标识
DOI:10.1002/adtp.202200007
摘要
Abstract Depression is one of the most prevalent mental diseases and a primary cause of disability worldwide with high incidence and high recurrence. The current deterioration of the COVID‐19 epidemic also pushes up the incidence of depression. Nevertheless, the currently available treatments remain inadequate response and limited efficacy. Therefore, discoveries of more potent and safer antidepressant drugs are urgently needed. In this review, the current potential physiological and pathological mechanisms of depression, and the clinical research progresses of candidate drugs as well as the recent advances in small‐molecule drug discovery for potential treatments of depression are systematically summarized. More importantly, the structure–activity relationships of compounds from different classes, the statistical analysis of the blood‐brain barrier permeability, the pharmacological targets, and the in vivo models are comprehensively discussed. Further insights on antidepressant drug discovery are also analyzed from multidimensional perspectives.
科研通智能强力驱动
Strongly Powered by AbleSci AI